{"id":17783,"date":"2019-10-18T09:13:49","date_gmt":"2019-10-18T07:13:49","guid":{"rendered":"https:\/\/www.curus.se\/nyheter\/findout-diagnostic-launches-finnish-success-promilless-0-2-%e2%80%b0-in-sweden\/"},"modified":"2019-10-18T09:13:49","modified_gmt":"2019-10-18T07:13:49","slug":"findout-diagnostic-launches-finnish-success-promilless-0-2-%e2%80%b0-in-sweden","status":"publish","type":"post","link":"https:\/\/www.curus.se\/en\/nyheter\/findout-diagnostic-launches-finnish-success-promilless-0-2-%e2%80%b0-in-sweden\/","title":{"rendered":"FindOut Diagnostic launches Finnish success Promilless 0.2 \u2030 in Sweden"},"content":{"rendered":"

Denise Luxenburg Stuifbergen, CEO FindOut Diagnostic<\/em><\/p>\n

Add Health Media’s associated company FindOut Diagnostic is now launching a new alcohol test that will give consumers a simpler and more cost-effective alternative to the conventional breath tests. Promilless 0.2 \u2030 is based on saliva and is unique in its kind because it is developed for the consumer.<\/strong> Promilless 0.2 \u2030 is an easy-to-use and reliable saliva test strip that quickly shows if you are fit to drive. The test consists of two test strips which, after contact with saliva, indicate within 2 minutes whether the alcohol concentration in the blood falls below or exceeds 0.2 \u2030. Measuring blood alcohol concentration through saliva is a scientifically proven and reliable method. The technology behind the test is based on generally known biochemical reactions. The biochemical dyes are printed and dispensed on a substrate (the reactive zone of the test) which reacts on contact with saliva to form a dye reaction which gives the user clear information about the test result. – Promilless 0.2 \u2030 has been developed for consumers in the Nordic market. Our customer surveys show that Swedes are responsible and interested in using the patented alcohol test Promilless 0.2 \u2030 to test their driving ability, says Petri S\u00e4rkel\u00e4, CEO of Goodwiller Ltd. Promilless 0.2 \u2030 was developed by Goodwiller together with the VTT Technical Research Center of Finland. Since their launch in mid-2017, they have sold over 350,000 tests in Finland with retailers such as the alcohol monopoly Alko, K-Market and pharmacies. – FindOut AB was chosen as our partner in Sweden due to their unique category knowledge and access to the trade, says Petri. The manufacturer Goodwiller received a patent for Promilless in the USA last week and has chosen the Swedish market as the first international investment. Promilless 0.2 \u2030 is currently being launched by FindOut Diagnostic AB through an exclusive collaboration with the Finnish manufacturer. – We see that the interest in self-tests is increasing and with Promilless 0.2 \u2030 we give the consumer the opportunity to in a simple, fast and reliable way be able to check whether to drive before doing so. The product is designed to fit in your wallet, so you can take Promilless 0.2 \u2030 with you in all situations, says Denise Luxenburg Stuifbergen, CEO of FindOut Diagnostic AB. When used correctly, Promilless 0.2 \u2030 is very reliable as it has a self-controlling function that has been developed and patented. This function checks every time the test is used that the test strip works and that the result is reliable. In this way, misleading results are prevented in e.g. incorrect storage of the test or use of the test after the expiry date. – Right now the product is available online but will soon be available for purchase in physical stores and pharmacies. We are also looking into changing the material of the test strips from plastic to cardboard, making it even more environmentally positive,” says Denise Luxenburg Stuifbergen. <\/p>\n

<\/div>\n
\"\"<\/div>\n
\n

More information at: www.promilless.se<\/em>Contact us<\/strong><\/p>\n<\/div>\n

Denise Luxenburg Stuifbergen, CEO FindOut Diagnostic + 46 (0) 768 52 44 62, Denise@findout.s Johan Bloom, Business Development Add Health Media +46 (0) 733 648 490, johan.bloom@addhealthmedia.com About FindOut Diagnostic<\/strong> FindOut’s vision is to make health data available on the individual’s terms through the development, manufacture and distribution of diagnostic self-tests on the European market. In the product portfolio, FindOut already has FindOut Celiac Test (gluten intolerance) and BlueGreenTest (Hepatotoxins). www.findout.se About Add Health Media<\/strong> Add Health Media is one of the Nordic region’s largest media houses in health and medicine and operates DOKTORN for the general public and patients, which includes a magazine, brochure stand and waiting room TV, as well as one of the Nordic region’s most visited websites www.doktorn.com. Add Health Media also runs Praktisk Medicin, www.praktisktmedicin.se, a decision support for healthcare staff, and invests in new start-ups in e-health, such as FindOut Diagnostic, Doctrin, Mindler, Colivia (formerly Nurse & Doc), Medicheck, Remisshj\u00e4lpen , ScientificMed, Picture My Life and Healthmakers. www.addhealthmedia.se<\/p>\n","protected":false},"excerpt":{"rendered":"

Denise Luxenburg Stuifbergen, CEO FindOut Diagnostic Add Health Media’s associated company FindOut Diagnostic is now launching a new alcohol test that will give consumers a simpler and more cost-effective alternative to the conventional breath tests. Promilless 0.2 \u2030 is based on saliva and is unique in its kind because it is developed for the consumer. […]<\/p>\n","protected":false},"author":24,"featured_media":15186,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[315,312,302],"tags":[],"class_list":["post-17783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-add-health-media-en-2","category-innovation-en-2","category-intressebolag-en"],"_links":{"self":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts\/17783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/comments?post=17783"}],"version-history":[{"count":0,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts\/17783\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/media\/15186"}],"wp:attachment":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/media?parent=17783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/categories?post=17783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/tags?post=17783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}